Top Gene editing companies by Market Cap
Browse the largest Gene editing companies in the world ranked by their Market Capitalization. Global Gene editing Companies market cap is $309.25B.
14 Sept 2024, 12:03 UTC
Companies: 21
🇺🇸1 |  | $1,157.44 | -0.60% | 124.00B | 32.44% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸2 |  | $478.65 | 0.82% | 123.35B | 18.19% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸3 |  | $195.63 | -1.14% | 28.31B | -24.04% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸4 |  | $126.25 | 1.14% | 20.05B | -8.44% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇭5 |  | $48.96 | 6.69% | 3.89B | -20.83% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳6 |  | $1.49 | 3.19% | 3.17B | -41.23% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸7 |  | $26.30 | 7.79% | 2.14B | -2.41% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸8 |  | $20.67 | 2.12% | 1.85B | -31.21% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸9 |  | $5.65 | -3.75% | 454.40M | -59.12% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸10 |  | $4.10 | 1.23% | 399.03M | -53.57% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷11 |  | $43.47 | 6.84% | 341.50M | -16.95% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸12 |  | $40.44 | -2.48% | 323.98M | -14.21% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸13 |  | $3.95 | 5.33% | 322.61M | -60.50% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳14 |  | $3.16 | 5.49% | 246.49M | -41.33% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸15 |  | $7.72 | 3.07% | 155.77M | 28.67% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸16 |  | $0.83 | 2.05% | 146.60M | 53.07% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸17 |  | $0.61 | 6.28% | 116.76M | -55.78% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵18 |  | $0.91 | 4.00% | 76.74M | -24.42% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵19 |  | $3.21 | -1.53% | 10.90M | -3.00% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇮🇱20 |  | $0.68 | 0.00% | 2.24M | -25.29% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇦21 |  | $0.04 | 0.00% | 1.42M | 25.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
